Definium Therapeutics US, Inc.
Quick facts
Phase 3 pipeline
- MM120 (LSD D-Tartrate) · Psychiatry / Mental Health
MM120 is a formulated version of LSD (lysergic acid diethylamide) that acts as a serotonin 5-HT receptor agonist, particularly at 5-HT1A and 5-HT2A receptors, to modulate neural circuits involved in mood and perception.
Phase 2 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: